ETV1 and Ewing sarcoma: At the same time, YK-4-279 has been shown to inhibit ERG and ETV1 transcription in prostate cancer cells [39], therefore, it might also be active against Ewing sarcoma cells with commonly and less commonly presented fusion in the tumors with Ewing sarcoma.